Latest Insider Transactions at Encompass Health Corp (EHC)
This section provides a real-time view of insider transactions for Encompass Health Corp (EHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Encompass Health Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Encompass Health Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2024
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
488
+24.7%
|
$34,160
$70.51 P/Share
|
|
Jan 16
2024
|
Greg D Carmichael Director |
BUY
Small Acquisition
|
Direct |
4
+0.03%
|
$272
$68.64 P/Share
|
|
Jan 16
2024
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.16%
|
-
|
|
Jan 16
2024
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+0.12%
|
-
|
|
Jan 16
2024
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.3%
|
-
|
|
Jan 16
2024
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.21%
|
-
|
|
Jan 16
2024
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.21%
|
-
|
|
Jan 16
2024
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.21%
|
-
|
|
Jan 16
2024
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
208
+0.21%
|
-
|
|
Jan 16
2024
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.18%
|
-
|
|
Jan 16
2024
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.19%
|
-
|
|
Jan 16
2024
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.21%
|
-
|
|
Jan 16
2024
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.21%
|
-
|
|
Jan 02
2024
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,288
-8.85%
|
$679,008
$66.72 P/Share
|
|
Jan 02
2024
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,281
-9.88%
|
$150,546
$66.72 P/Share
|
|
Jan 02
2024
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,062
-2.85%
|
$136,092
$66.72 P/Share
|
|
Jan 02
2024
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,935
-1.97%
|
$127,710
$66.72 P/Share
|
|
Jan 02
2024
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,920
-6.55%
|
$324,720
$66.72 P/Share
|
|
Jan 02
2024
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,159
-5.06%
|
$1,660,494
$66.72 P/Share
|
|
Nov 27
2023
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
997
+50.0%
|
-
|
|
Nov 13
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,215
-8.8%
|
$706,545
$63.39 P/Share
|
|
Nov 13
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,623
+11.53%
|
$432,198
$26.55 P/Share
|
|
Oct 17
2023
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.05%
|
$256
$64.5 P/Share
|
|
Oct 17
2023
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
541
+0.33%
|
$34,624
$64.58 P/Share
|
|
Oct 16
2023
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.23%
|
-
|
|
Oct 16
2023
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.23%
|
-
|
|
Oct 16
2023
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.24%
|
-
|
|
Oct 16
2023
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.2%
|
-
|
|
Oct 16
2023
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.24%
|
-
|
|
Oct 16
2023
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
231
+0.23%
|
-
|
|
Oct 16
2023
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.23%
|
-
|
|
Oct 16
2023
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.19%
|
-
|
|
Oct 16
2023
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.21%
|
-
|
|
Oct 16
2023
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.14%
|
-
|
|
Aug 17
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,294
-26.44%
|
$572,286
$69.58 P/Share
|
|
Aug 16
2023
|
Mark J Tarr President & CEO |
SELL
Open market or private sale
|
Direct |
25,330
-4.85%
|
$1,798,430
$71.06 P/Share
|
|
Aug 16
2023
|
Mark J Tarr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,330
+4.62%
|
$658,580
$26.55 P/Share
|
|
Jul 18
2023
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.05%
|
$268
$67.7 P/Share
|
|
Jul 18
2023
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
448
+0.28%
|
$30,016
$67.73 P/Share
|
|
Jul 17
2023
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
39
+0.22%
|
-
|
|
Jul 17
2023
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.22%
|
-
|
|
Jul 17
2023
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.22%
|
-
|
|
Jul 17
2023
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.19%
|
-
|
|
Jul 17
2023
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
95
+0.22%
|
-
|
|
Jul 17
2023
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
95
+0.22%
|
-
|
|
Jul 17
2023
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.18%
|
-
|
|
Jul 17
2023
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.19%
|
-
|
|
Jul 17
2023
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
218
+0.22%
|
-
|
|
Jul 17
2023
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
209
+0.13%
|
-
|
|
May 04
2023
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,385
+17.63%
|
-
|